WallStSmart

Arcosa Inc (ACA)vsCaterpillar Inc (CAT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Caterpillar Inc generates 2244% more annual revenue ($67.59B vs $2.88B). CAT leads profitability with a 13.1% profit margin vs 7.2%. ACA appears more attractively valued with a PEG of 1.55. ACA earns a higher WallStSmart Score of 59/100 (C).

ACA

Buy

59

out of 100

Grade: C

Growth: 7.3Profit: 5.5Value: 4.0Quality: 6.0
Piotroski: 3/9Altman Z: 1.73

CAT

Buy

55

out of 100

Grade: C-

Growth: 4.7Profit: 7.5Value: 4.3Quality: 4.5
Piotroski: 3/9Altman Z: 2.40
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ACASignificantly Overvalued (-20.2%)

Margin of Safety

-20.2%

Fair Value

$106.33

Current Price

$126.47

$20.14 premium

UndervaluedFair: $106.33Overvalued

Intrinsic value data unavailable for CAT.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ACA2 strengths · Avg: 9.0/10
EPS GrowthGrowth
335.3%10/10

Earnings expanding 335.3% YoY

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

CAT4 strengths · Avg: 9.0/10
Market CapQuality
$414.16B10/10

Mega-cap, among the largest globally

Return on EquityProfitability
43.5%10/10

Every $100 of equity generates 44 in profit

Revenue GrowthGrowth
18.0%8/10

18.0% revenue growth

Free Cash FlowQuality
$2.25B8/10

Generating 2.2B in free cash flow

Areas to Watch

ACA4 concerns · Avg: 3.8/10
PEG RatioValuation
1.554/10

Expensive relative to growth rate

P/E RatioValuation
27.5x4/10

Moderate valuation

Altman Z-ScoreHealth
1.734/10

Distress zone — elevated risk

Profit MarginProfitability
7.2%3/10

7.2% margin — thin

CAT4 concerns · Avg: 3.3/10
PEG RatioValuation
2.174/10

Expensive relative to growth rate

Price/BookValuation
19.4x4/10

Trading at 19.4x book value

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

P/E RatioValuation
44.2x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : ACA

The strongest argument for ACA centers on EPS Growth, Price/Book.

Bull Case : CAT

The strongest argument for CAT centers on Market Cap, Return on Equity, Revenue Growth. Revenue growth of 18.0% demonstrates continued momentum.

Bear Case : ACA

The primary concerns for ACA are PEG Ratio, P/E Ratio, Altman Z-Score.

Bear Case : CAT

The primary concerns for CAT are PEG Ratio, Price/Book, Piotroski F-Score. A P/E of 44.2x leaves little room for execution misses. Debt-to-equity of 2.03 is elevated, increasing financial risk.

Key Dynamics to Monitor

ACA profiles as a value stock while CAT is a growth play — different risk/reward profiles.

CAT carries more volatility with a beta of 1.52 — expect wider price swings.

CAT is growing revenue faster at 18.0% — sustainability is the question.

CAT generates stronger free cash flow (2.2B), providing more financial flexibility.

Bottom Line

ACA scores higher overall (59/100 vs 55/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Arcosa Inc

INDUSTRIALS · ENGINEERING & CONSTRUCTION · USA

Arcosa, Inc. provides infrastructure related products and solutions for the construction, energy and transportation markets in North America. The company is headquartered in Dallas, Texas.

Visit Website →

Caterpillar Inc

INDUSTRIALS · FARM & HEAVY CONSTRUCTION MACHINERY · USA

Caterpillar Inc. (often shortened to CAT) is an American Fortune 100 corporation that designs, develops, engineers, manufactures, markets, and sells machinery, engines, financial products, and insurance to customers via a worldwide dealer network.

Visit Website →

Want to dig deeper into these stocks?